Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Lancet. Neurology|August 10, 2019
Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trialRebecca Palmer, Munyaradzi Dimairo, Cindy Cooper, et al.Age and Ageing|June 21, 2011
Rehabilitation of older patients: day hospital compared with rehabilitation at home. Clinical outcomesStuart G Parker, Phillip Oliver, Mark Pennington, et al.Plos One|March 20, 2026
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in UK primary care: An internal pilot for a cluster randomised controlled trialKirstie McClatchey, Daisy Bertram, Atena Barat, et al.Health Technology Assessment (Winchester, England)|May 6, 2020
Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCTRebecca Palmer, Munyaradzi Dimairo, Nicholas Latimer, et al.BMJ Health & Care Informatics|January 9, 2025
Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied ResearchHolly Tibble, Rami A Alyami, Andrew Bush, et al.The British Journal of Dermatology|December 18, 2025
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trialMaria L Bageta, Pablo López Balboa, Matt Bursnall, et al.Plos One|October 19, 2021
Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported informationBrooklyn Stanley, Andrew Davis, Rupert Jones, et al.Eclinicalmedicine|November 3, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phaseMaria L Bageta, Pablo Lopez-Balboa, Matt Bursnall, et al.Pragmatic and Observational Research|August 19, 2021
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested PatientsRupert Jones, Andrew Davis, Brooklyn Stanley, et al.Pageof 4